10170 related articles for article (PubMed ID: 10919159)
21. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
[TBL] [Abstract][Full Text] [Related]
22. Technetium-99m-tetrofosmin: a new agent for melanoma imaging?
Meghdadi S; Karanikas G; Schlagbauer-Wadl H; Jansen B; Chehne F; Rodrigues M; Pehamberger H; Sinzinger H
Anticancer Res; 1998; 18(4A):2759-62. PubMed ID: 9703942
[TBL] [Abstract][Full Text] [Related]
23. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I
Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
[TBL] [Abstract][Full Text] [Related]
24. Detection of melanoma metastases with thallium-201 scintigraphy.
Rettenbacher L; Koller J; Kässmann H; Galvan G
J Nucl Med; 1998 May; 39(5):798-802. PubMed ID: 9591578
[TBL] [Abstract][Full Text] [Related]
25. Scintimammography with technetium-99m tetrofosmin in suspected breast cancer.
Schillaci O; Scopinaro F; Danieli R; Picardi V; Tavolaro R; Cannas P; Colella AC
Anticancer Res; 1997; 17(3B):1623-6. PubMed ID: 9179206
[TBL] [Abstract][Full Text] [Related]
26. [Use of a gamma probe for intraoperative localization of parathyroid adenomas with Tc-99m-tetrofosmin and Tc-99m-sestamibi].
Gallowitsch HJ; Fellinger J; Kresnik E; Mikosch P; Pipam W; Unterweger OF; Lind P
Acta Med Austriaca; 1997; 24(2):73-8. PubMed ID: 9273810
[TBL] [Abstract][Full Text] [Related]
27. Detection and follow-up of metastatic melanoma before and after high-dose regional chemotherapy by isolated limb perfusion with Tc-99m tetrofosmin.
Rettenbacher L; Koller J; Kässmann H; Galvan G
Clin Nucl Med; 1999 Dec; 24(12):976-7. PubMed ID: 10595481
[No Abstract] [Full Text] [Related]
28. Technetium-99m tetrofosmin scintigraphy to evaluate breast lesions.
Madariaga P; Almoguera I; Alonso A; Escat JL; Vegazo O; Martinez ML; Trampal C; Perez Vazquez JM
Anticancer Res; 1997; 17(3B):1619-21. PubMed ID: 9179205
[TBL] [Abstract][Full Text] [Related]
29. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M
J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
[TBL] [Abstract][Full Text] [Related]
30. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
[TBL] [Abstract][Full Text] [Related]
31. Technetium-99m tetrofosmin and technetium-99m sestamibi imaging of multiple metastases from differentiated thyroid carcinoma.
Kosuda S; Yokoyama H; Katayama M; Yokokawa T; Kusano S; Yamamoto O
Eur J Nucl Med; 1995 Oct; 22(10):1218-20. PubMed ID: 8542909
[TBL] [Abstract][Full Text] [Related]
32. The clinical usefulness of (99m)Tc-Tetrofosmin scintigraphy in the diagnosis of lung neoplasmas and mediastinal lymphoid node involvement.
Huang D; Zhao F; Zhang Y
J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):608-12. PubMed ID: 18846350
[TBL] [Abstract][Full Text] [Related]
33. An open-label, multicenter, phase 2a study to assess the feasibility of imaging metastases in late-stage cancer patients with the alpha v beta 3-selective angiogenesis imaging agent 99mTc-NC100692.
Axelsson R; Bach-Gansmo T; Castell-Conesa J; McParland BJ;
Acta Radiol; 2010 Feb; 51(1):40-6. PubMed ID: 20001475
[TBL] [Abstract][Full Text] [Related]
34. Scintimammography using Tc-99m tetrofosmin.
Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I
Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787
[TBL] [Abstract][Full Text] [Related]
35. Thallium-201-chloride and technetium-99m-MIBI SPECT of primary and metastatic lung carcinoma.
Kashitani N; Makihara S; Maeda T; Eda R; Takeyama H; Hiraki Y
Oncol Rep; 1999; 6(1):127-33. PubMed ID: 9864415
[TBL] [Abstract][Full Text] [Related]
36. Technetium-99m tetrofosmin scintigraphy for detecting malignant lymphoma.
Lee JK; Tsai SC; Ho YJ; Changlai SP; Kao CH
Anticancer Res; 2001; 21(2B):1509-13. PubMed ID: 11396241
[TBL] [Abstract][Full Text] [Related]
37. Detection of recurrent malignant melanoma with 99mTc-MIBI scintigraphy.
Alonso O; Martinez M; Mut F; Delgado L; Lago G; De Boni D; Bazzano C; Núñez M; Garcés M; Muse IM; Roca R; Touya E; Espasandín J; Priario J
Melanoma Res; 1998 Aug; 8(4):355-60. PubMed ID: 9764811
[TBL] [Abstract][Full Text] [Related]
38. Characterization of breast lesion using double phase Tc-99m Tetrofosmin scintimammography: comparison of visual and quantitative analyses.
Lee JS; Kim SJ; Kim IJ; Bae YT; Kim YK; Kang YS; Kim DS
Eur J Radiol; 2006 Jan; 57(1):76-80. PubMed ID: 16125892
[TBL] [Abstract][Full Text] [Related]
39. Assessment of thyroid nodules by technetium-99m-tetrofosmin scintigraphy.
Akçay G; Uslu H; Varoglu E; Tekin SB; Gündogdu C
Br J Clin Pract; 1997; 51(1):5-7. PubMed ID: 9158263
[TBL] [Abstract][Full Text] [Related]
40. Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: comparison with thallium-201 imaging.
Soricelli A; Cuocolo A; Varrone A; Discepolo A; Tedeschi E; Mainenti PP; Grivet-Fojaja MR; Covelli EM; Postiglione A; Salvatore M
J Nucl Med; 1998 May; 39(5):802-6. PubMed ID: 9591579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
